LNTH: Lantheus Holdings, Inc. Stock

by  •  • Comments Off on LNTH: Lantheus Holdings, Inc. Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 4,469.55
Enterprise Value ($M) 4,317.57
Book Value ($M) 815.89
Book Value / Share 11.90
Price / Book 5.48
NCAV ($M) 250.56
NCAV / Share 3.66
Price / NCAV 17.84

Profitability (mra)
Return on Invested Capital (ROIC) 0.23
Return on Assets (ROA) 0.24
Return on Equity (ROE) 0.73

Liquidity (mrq)
Quick Ratio 5.45
Current Ratio 5.80

Balance Sheet (mrq) ($M)
Current Assets 1,085.82
Assets 1,651.15
Liabilities 835.26
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,296.43
Operating Income 364.64
Net Income 326.66
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 305.26
Cash from Investing 5.94
Cash from Financing -13.06

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G Janus Henderson Group Plc 5.80
02-13 13G/A Vanguard Group Inc 10.18 -3.78
01-23 13G/A BlackRock Inc. 12.60 4.71

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-04 10-Q Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 95,456 424,665 22.48
2024-04-25 125,812 239,328 52.57
2024-04-24 89,876 279,827 32.12
2024-04-23 108,488 239,826 45.24

(click for more detail)

Similar Companies
KYMR – Kymera Therapeutics, Inc. LBPH – Longboard Pharmaceuticals, Inc.
LGND – Ligand Pharmaceuticals Incorporated LRMR – Larimar Therapeutics, Inc.
LUMO – Lumos Pharma, Inc.


Financial data and stock pages provided by
Fintel.io